Goat Anti-Human IgA alpha chain (HRP) preadsorbed (ab98558)
Key features and details
- Goat Anti-Human IgA alpha chain (HRP) preadsorbed
- Conjugation: HRP
- Host species: Goat
- Isotype: IgG
- Suitable for: ELISA, WB, IHC-P, ICC
Overview
-
Product name
Goat Anti-Human IgA alpha chain (HRP) preadsorbed
See all IgA secondary antibodies -
Host species
Goat -
Target species
Human -
Tested applications
Suitable for: ELISA, WB, IHC-P, ICCmore details -
Minimal
cross-reactivity
Mouse, Rat more details -
Conjugation
HRP
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C. -
Storage buffer
pH: 6.8
Constituents: 0.2% BSA, 0.05% CMIT/MIT based preservative -
Concentration information loading...
-
Purity
Immunogen affinity purified -
Purification notes
This antibody was isolated by affinity chromatography using antigen coupled to agarose beads and conjugated to Horse Radish Peroxidase. -
Clonality
Polyclonal -
Isotype
IgG -
Research areas
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab98558 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
ELISA |
1/10000 - 1/100000. (as Primary).
|
|
WB |
1/2000 - 1/25000. (Colorimetric: 1/2000 - 1/20000; Chemiluminescent: 1/5000 - 1/25000).
|
|
IHC-P |
1/200 - 1/2000.
|
|
ICC |
Use at an assay dependent dilution.
|
Notes |
---|
ELISA
1/10000 - 1/100000. (as Primary). |
WB
1/2000 - 1/25000. (Colorimetric: 1/2000 - 1/20000; Chemiluminescent: 1/5000 - 1/25000). |
IHC-P
1/200 - 1/2000. |
ICC
Use at an assay dependent dilution. |
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (2)
ab98558 has been referenced in 2 publications.
- Meinberger D et al. Analysis of IgM, IgA, and IgG isotype antibodies Directed against SARS-CoV-2 spike glycoprotein and ORF8 in the course of COVID-19. Sci Rep 11:8920 (2021). PubMed: 33903660
- Dedrick RM et al. Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection. Nat Med 27:1357-1361 (2021). PubMed: 34239133